Humira
Novartis’ Cosentyx Clinches First Approval for Hidradenitis Suppurativa Treatment
Novartis’ Cosentyx has gained an early lead in the field of hidradenitis suppurativa (HS), a painful skin condition, potentially giving ...
Teva and Alvotech face FDA rejection for Stelara biosimilar after Humira setbacks
Ongoing issues at the Alvotech manufacturing facility in Reykjavik have led to yet another FDA rejection, this time affecting the ...
Boehringer Ingelheim Adopts Dual-Pricing Strategy with Launch of Unbranded Humira Biosimilar
Boehringer Ingelheim, the company that recently introduced the first interchangeable biosimilar to AbbVie’s blockbuster drug Humira, is now embracing a ...
FDA Approves 5-Minute Tests for Monitoring Humira and Remicade Doses in Inflammatory Bowel Disease Patients
The FDA has recently granted two de novo clearances to ProciseDx, marking a significant advancement in personalized medicine for patients ...
Biocon Biologicsā CEO reveals pricing strategy and device design for Hulio, its Humira biosimilar, in the US market
The competition in the biosimilar arena targeting AbbVie’s blockbuster drug Humira, also known as adalimumab, is heating up. However, for ...
Humira sales decline as biosimilars gain traction, but physicians remain wary of switching patients
In the race to capture a share of the $20 billion annual revenue generated by AbbVie’s blockbuster biologic, Humira biosimilars ...
Alvotech Seeks Interchangeability Status for Humira Biosimilar Again
Alvotech is forging an audacious path towards a potential game-changer. CEO Robert Wessman recently unveiled a resubmission of their Biologics ...
Prescription Drug Cost Concerns Escalate to Shared ‘Core Value’ Across Party Lines, Survey Finds
Mounting worries over the soaring costs of prescription drugs have transcended political boundaries to become a deeply entrenched concern among ...
Humira Biosimilars: Benefits, Availability, Price, Comparison and More
In this article, we will give you an overview of Humira biosimilars, including their benefits, availability, prices, and how they ...
How Skyrizi Outspent Other Drugs in a Tough Market
In July, AbbVie’s Skyrizi maintained its position as the top pharma drug ad spender for the second consecutive month, but ...
Samsung wants to describe its Humira biosimilar as “interchangeable.”
While several biosimilars of AbbVie’s top-selling drug, Humira, are already available in the US market, only one, Boehringer Ingelheim’s Cyltezo, ...
AbbVie Raises Profit Expectations Despite Q2 Decrease in Humira and Imbruvica Sales
AbbVie executives express satisfaction with the introduction of Humira biosimilars in the US, despite facing significant revenue declines for both ...
Teva Expands Alvotech Collaboration with 2 New Biosimilar, $40M Investment & Enhanced Oversight
Source – Teva Pharmaceuticals Following the second FDA rejection of Teva’s Alvotech-partnered biosimilar for Humira, the two companies are expanding ...
Humira biosimilar to be made available by RxPreferred via Mark Cuban’s online pharmacy
Pharmacy benefits manager (PBM) RxPreferred has unveiled its plan to provide the Humira biosimilar Yusimry through Mark Cuban Cost Plus ...
Ex-baseball player hired by AbbVie to help de-stigmatize bowel condition as part of their post-Humira growth strategy
In his second season playing professional baseball, Fowler, who won the World Series with the Chicago Cubs in 2016, had ...
